Free Trial

Headlands Technologies LLC Has $1.47 Million Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Key Points

  • Headlands Technologies LLC significantly increased its stake in DENTSPLY SIRONA Inc. by 1,657.9%, owning 98,109 shares worth approximately $1.47 million after a purchase of 92,528 additional shares.
  • Institutional investors control 95.70% of DENTSPLY SIRONA's stock, with several funds like Mirae Asset Global Investments also acquiring new stakes in the company.
  • Analyst ratings for DENTSPLY SIRONA indicate an average rating of "Hold" with a consensus price target of $19.60, as reports from various firms present mixed outlooks on the stock's future performance.
  • Looking to export and analyze DENTSPLY SIRONA data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Headlands Technologies LLC boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1,657.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 98,109 shares of the medical instruments supplier's stock after purchasing an additional 92,528 shares during the quarter. Headlands Technologies LLC's holdings in DENTSPLY SIRONA were worth $1,466,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth about $25,000. Colonial Trust Co SC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. True Wealth Design LLC grew its stake in shares of DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares during the last quarter. Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock worth $54,000 after purchasing an additional 2,517 shares during the last quarter. Finally, Quarry LP grew its stake in shares of DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Barrington Research set a $18.00 price objective on shares of DENTSPLY SIRONA and gave the stock an "outperform" rating in a research note on Friday. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 30th. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday. Twelve analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average target price of $18.64.

Read Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Up 2.6%

XRAY stock traded up $0.33 during trading hours on Tuesday, hitting $12.86. The company's stock had a trading volume of 1,218,748 shares, compared to its average volume of 2,981,708. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market capitalization of $2.56 billion, a PE ratio of -2.71, a price-to-earnings-growth ratio of 0.80 and a beta of 0.94. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.48. The stock has a 50 day moving average price of $15.64 and a two-hundred day moving average price of $15.82.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA's quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 EPS. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.0%. DENTSPLY SIRONA's dividend payout ratio is -13.50%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines